Inguino-scrotal hernia of a double district ureter: case report and literature review.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 15611836)

Published in Hernia on October 22, 2005

Authors

L Bertolaccini1, G Giacomelli, R E Bozzo, L Gastaldi, M Moroni

Author Affiliations

1: Department of Surgical Activity, Maria Vittoria Hospital, Cibrario St. 72, 10149 Turin, Italy. l.bertolaccini@vodafone.it

Articles cited by this

Hernias of the ureter.--An anatomic-roentgenographic study. Radiology (1975) 1.95

Scrotal extraperitoneal hernia of the ureter: case report and literature review. Urol Int (2001) 1.76

Accidental ureteral ligation during an inguinal hernia repair of patient with crossed fused renal ectopia. Clin Imaging (2002) 1.70

Scrotal incarceration of the ureter with crossed renal ectopia: case report and literature review. J Urol (1989) 1.50

Ureteroinguinal hernia: a rare companion of sliding inguinal hernias. Am Surg (1991) 1.48

Intrascrotal hernia of the ureter and fatty hernia. Hernia (2002) 1.25

Sliding inguinal hernia containing the ureter: a case report. J Urol (1996) 1.22

[Intrascrotal herniation of the ureter]. Ann Chir (2002) 0.99

Ureter within a sliding inguinal hernia. Can J Surg (1983) 0.92

Ureteral herniation: case report and literature review. Mt Sinai J Med (1986) 0.83

Bilateral megaureters presenting as an inguinal hernia. J Pediatr Surg (1985) 0.81

Inguinal prolapse of retroperitoneal fat ("fatty hernia"). Report of a case also involving the ureter. Acta Chir Scand (1966) 0.81

[Inguinal hernia containing bladder and ureter. A clinical case]. Minerva Chir (1994) 0.76

Herniation of ureter in inguinal hernia. Trop Doct (1995) 0.76

[The involvement of the urinary tract in inguinal hernias]. Ann Ital Chir (1999) 0.76

[Acute obstructive renal failure and scrotal complete hernia of the bladder. Apropos of a case, review of the literature]. J Chir (Paris) (1996) 0.75

[Inguino-scrotal hernia of the ureter. A case report with computerized tomography findings]. Radiol Med (1997) 0.75

[An unusual case of inguinal hernia with intestinal and ureteral content]. Radiol Med (1984) 0.75

Inguinal herniation of the ureter. Pediatr Radiol (1977) 0.75

Articles by these authors

(truncated to the top 100)

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS (2000) 4.55

Does lead overload develop in hemodialysis patients? Nephron (1989) 2.52

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50

Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64

Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48

High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47

Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol (2009) 1.45

When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41

Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology (2000) 1.39

Acute renal failure and Mediterranean spotted fever. Nephron (1990) 1.38

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36

Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res (1998) 1.36

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS (1998) 1.35

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32

HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31

Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31

Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31

Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29

An easy and convenient synthesis of Weinreb amides and hydroxamates. J Org Chem (2001) 1.24

Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24

Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (1996) 1.23

AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS (1992) 1.20

Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18

Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors. Antimicrob Agents Chemother (2000) 1.17

Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med (1992) 1.16

Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16

Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer. Lancet (1990) 1.09

Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J (1988) 1.08

[Contribution of immunofluorescence tests to the biological diagnosis of hydatidosis]. G Mal Infett Parassit (1966) 1.08

Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol (1988) 1.07

Prospective study of epidemic delta infection in drug addicts. Prog Clin Biol Res (1983) 1.07

Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood (2001) 1.05

Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings. Histol Histopathol (1992) 1.05

Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04

Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science (1997) 0.99

Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron (1991) 0.98

[Echocardiographic studies with a multiscanner apparatus]. G Ital Cardiol (1976) 0.98

Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses (1996) 0.97

Disseminated Rhodococcus equi infection initially presenting as foot mycetoma in an HIV-positive patient. AIDS (1992) 0.97

Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis (2001) 0.96

Clinical features of sporadic non-A, non-B hepatitis possibly associated with faecal-oral spread. Lancet (1985) 0.95

Inosiplex in recurrent herpes simplex infections. Lancet (1982) 0.95

A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol (1997) 0.94

Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS (1997) 0.94

Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group. JAMA (1992) 0.93

HIV-1 infection, tuberculosis, and syphilis in male transsexual prostitutes in Milan, Italy. J Acquir Immune Defic Syndr (1991) 0.93

CD4 cell counts at the third month of HAART may predict clinical failure. AIDS (1999) 0.93

IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Br Med J (Clin Res Ed) (1985) 0.92

Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92

Prolonged course and relapses of acute type A hepatitis. Boll Ist Sieroter Milan (1984) 0.91

Simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 0.91

Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine. J Acquir Immune Defic Syndr (1999) 0.90

Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer. Ann Oncol (2005) 0.90

Solid-phase synthesis of isoxazole-based amino acids: a new scaffold for molecular diversity. J Org Chem (2001) 0.90

Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS (1996) 0.90

Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol (1998) 0.89

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis (1997) 0.89

Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis (1995) 0.89

Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem (1999) 0.89

In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol (2000) 0.89

Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. Eur J Ophthalmol (2007) 0.89

White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (1998) 0.88

An atypical form of alphaB-crystallin is present in high concentration in some human cataractous lenses. Identification and characterization of aberrant N- and C-terminal processing. J Biol Chem (1999) 0.88

Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 0.87

Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group. J Acquir Immune Defic Syndr (2000) 0.87

Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial. Antivir Ther (1997) 0.87

Co-Release of GABA Does Not Occur at Glycinergic Synapses onto Lumbar Motoneurons in Juvenile Mice. Front Cell Neurosci (2012) 0.87

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. Antimicrob Agents Chemother (2000) 0.87

The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin Endocrinol Metab (1994) 0.87

Metachronous occurrence of seminoma and Hodgkin's lymphoma in the same patient with late-onset colon cancer. J Intern Med (1994) 0.87

Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. Am J Gastroenterol (1994) 0.87

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group. AIDS (1993) 0.86

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin Infect Dis (2001) 0.86

A mild and efficient alternative to the classical Swern oxidation. J Org Chem (2001) 0.86

HIV-1 and HIV-2 infections in Italian AIDS/ARC patients. Lancet (1987) 0.85

[Emergency abdominal surgery in the aged]. Minerva Chir (1996) 0.85

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study. Eur J Cancer (1997) 0.85

Epidemiology of non-A, non-B hepatitis. Lancet (1980) 0.85

Clinical diagnosis of mycobacterial diseases versus autopsy findings in 350 patients with AIDS. Eur J Clin Microbiol Infect Dis (1996) 0.85

A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis (1991) 0.85

HIV type 1 phenotype correlates with the stage of infection in vertically infected children. AIDS Res Hum Retroviruses (1996) 0.85

Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein. Virology (2001) 0.84

Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. J Acquir Immune Defic Syndr (2000) 0.84

[Urinary excretion of 5-hydroxyindoleacetic acid during headache attacks induced with trinitroglycerin]. Boll Soc Ital Biol Sper (1967) 0.84

Natural history and treatment of uremia secondary to Fabry's disease: an European experience. Nephron (1987) 0.84

Monuril in lower uncomplicated urinary tract infections in adults. Eur Urol (1987) 0.83

The maturation and fate of reticulocytes after in vitro labeling with tritiated amino acids. Blood (1968) 0.83

New pentamidine analogues in medicinal chemistry. Curr Med Chem (2012) 0.83

HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Hum Immunol (1988) 0.83

Course and prognosis of acute HDV hepatitis. Prog Clin Biol Res (1987) 0.83

Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma (1998) 0.83

Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron (1988) 0.82

AIDS, zinc deficiency, and thymic hormone failure. JAMA (1988) 0.82

Immunoendocrinologic abnormalities in human immunodeficiency virus infection. Ann N Y Acad Sci (2000) 0.82

Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy. J Virol (1998) 0.82

Cetuximab for treatment of metastatic colorectal cancer. Ann Oncol (2006) 0.82

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. J Infect Dis (2000) 0.82

HTLV infection in ELISA-negative blood donors. AIDS Res Hum Retroviruses (1996) 0.82

High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients. AIDS Res Hum Retroviruses (1997) 0.82

Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc. Cancer Gene Ther (2006) 0.82